Abstract
The modulation of radioligand binding at Ri adenosine receptors of rat fat cells by guanine nucleotides and cations was investigated. Guanine nucleotides (in the order of potency: GTP = GDP greater than Gpp(NH)p greater than 5'-GMP) decreased the binding of the Ri receptor agonist (-)N6-phenylisopropyl[3H]adenosine([3H]PIA), but did not affect binding of the antagonist 1,3-diethyl-8-[3H]phenylxanthine ([3H]DPX). Saturation of [3H]PIA binding revealed that GTP (100 mumol/l) converts the high affinity form of the Ri receptor into a low affinity form. This effect was confirmed in kinetic experiments. GTP decreased the potency of agonists in competing for [3H]DPX binding, as shown by a 50-fold shift of the Ki-value for (-)PIA, whereas antagonist-induced inhibition of binding remained unchanged. The divalent cations Mg2+ and Ca2+ produced a slight increase in [3H]PIA binding, but did not affect [3H]DPX binding. Mn2+ markedly decreased both agonist and antagonist binding at Ri adenosine receptors. Divalent cations reversed the guanine nucleotide-induced decrease of affinity of the Ri receptor. Na+ did not significantly affect agonist or antagonist binding but abolished the stimulatory effect of Mg2+ on agonist binding in the presence of GTP. Our data indicate that guanine nucleotides convert the Ri adenosine receptor of rat fat cells from a high to a low agonist affinity state and that the modulation of radioligand binding by mono- and divalent cations differs from that of Ri receptors of other tissues.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.